One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Dynamic changes in prevalence of type 2 diabetes along with associated factors in Bangladesh: Evidence from two national cross-sectional surveys (BDHS 2011 and BDHS 2017–18)
Sabiha Shirin Sara a , Ashis Talukder a, *, Ka Yiu Lee b , Nayan Basak a , Shaharior Rahman Razu c , Iqramul Haq d , Chuton Deb Nath
doi : 10.1016/j.dsx.2023.102706
Volume 17, Issue 2, February 2023, 102706
Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational study
Mohamed Hassanein a, *, Rachid Malek b , Inass Shaltout c , Rakesh Kumar Sahay d , Mehmet Akif Buyukbese e , Khier Djaballah f , Valerie Pilorget f , Mathieu Coudert f , Saud Al Sifri
doi : 10.1016/j.dsx.2023.102707
Volume 17, Issue 2, February 2023, 102707
Association of type 2 diabetes with coronary risk factors, clinical presentation, angiography, coronary interventions and follow-up outcomes: A single centre prospective registry
Rajeev Gupta a, *, Sailesh Lodha b , Krishna Kumar Sharma c, f , Sanjeev K. Sharma d , Jitender S. Makkar d , Ajeet Bana e , Vishnu Natani c , Sumit Kumar c , Shilpa Bharati c , Samin K. Sharma
doi : 10.1016/j.dsx.2023.102709
Volume 17, Issue 2, February 2023, 102709
To determine variations in coronary artery disease (CAD) clinical presentation, interventions, and outcomes in patients with diabetes vs without, a prospective study was performed.
Isochromosome Xq and the risk of metabolic comorbidities in Turner syndrome
Rakhi Malhotra a, *, Rashmi Shukla b , Vandana Rastogi c , Rajesh Khadgawat
doi : 10.1016/j.dsx.2023.102708
Volume 17, Issue 2, February 2023, 102708
Subjects with Turner syndrome (TS) are at increased risk of metabolic disorders. The objective of this study is to evaluate the prevalence of metabolic abnormalities in TS and compare the metabolic profiles of subjects with respect to their X chromosome dosage.
Defining the optimum HOMA-IR cut-off value for insulin resistance among ARV-treated HIV patients in Indonesia
Dante S. Harbuwono a, b, *, Nenfiati a , Dicky L. Tahapary a, b , Siti Setiati c , Evy Yunihastuti d , Tri Juli Edi Tarigan
doi : 10.1016/j.dsx.2023.102719
Volume 17, Issue 2, February 2023, 102719
HIV-infected patients who are treated with anti-retroviral (ARV) drugs are prone to develop insulin resistance. This study aims to determine the cut-off value of HOMA-IR score in ARV-treated HIV patients in Indonesia.
Diabetes, Ramadan, and driving - Ensuring patient safety while respecting religious autonomy: A qualitative study
Christina San San Tan a , Yen Jun Wong b , Kar Foong Tang b , Shaun Wen Huey Lee
doi : 10.1016/j.dsx.2023.102724
Volume 17, Issue 2, February 2023, 102724
Hypoglycaemia due to fasting during Ramadan may affect the ability to perform complex activities among people with type 2 diabetes mellitus (T2D), but it is unclear how this affects one's ability to drive. This study aims to explore driving experiences and coping strategies to ensure safe driving among people with T2D who fast during Ramadan.
Association of C-peptide level with peripheral neuropathy in type 2 diabetes: An observational cross-sectional preliminary study
Umaid Potaliya, Sandeep Tak*, Manish Goyal
doi : 10.1016/j.dsx.2023.102725
Volume 17, Issue 2, February 2023, 102725
Peripheral neuropathy is the most common microvascular complication of diabetes mellitus. In subjects with type 1 diabetes (T1D) relationship of C-peptide levels and neuropathy has been observed in several studies, however, there are very few studies in type 2 diabetes (T2D) subjects.
Higher fasting fibroblast growth factor 21 was associated with a greater decline in postprandial blood pressure
Jane Yu Ying Ong a , Kaveri Pathak b , Yun Zhao b , Emily Calton b , Christopher M. Reid b, c , Mario J. Soares
doi : 10.1016/j.dsx.2023.102720
Volume 17, Issue 2, February 2023, 102720
A fall in blood pressure (BP) following a meal is well known and is usually a transient phenomenon, due to appropriate cardiovascular adjustments. Older individuals and those with high BP experience a greater postprandial fall that can manifest as postprandial hypotension (PPH).
The efficacy of intranasal oxytocin in patients with Prader-Willi syndrome: A systematic review and meta-analysis
Noran M. Shalma a, *, Mostafa A. Alsharabasy b , Amira M. Taha c , Ashraf Alsawareah d , Emery Manirambona e , Sirwan K. Ahmed f , Mohamed R. Mohamed g , Nouran A. Taha h , Mohamed Abd-ElGawad
doi : 10.1016/j.dsx.2023.102711
Volume 17, Issue 2, February 2023, 102711
Prader-Willi Syndrome (PWS) is a rare genetic disease. Oxytocin is a neuropeptide hormone that impacts fear, and social recognition. Intranasal administration of oxytocin can be utilized to treat PWS patients. The results of published trials assessing the effects of intranasal oxytocin in PWS are variable. The current systematic review aims to investigate the efficacy of oxytocin in Prader-Willi patients.
Efficacy and safety of imeglimin in type 2 diabetes: A systematic review and meta-analysis of randomized placebo-controlled trials
Awadhesh Kumar Singh a, *, Akriti Singh b , Ritu Singh a , Anoop Misra
doi : 10.1016/j.dsx.2023.102710
Volume 17, Issue 2, February 2023, 102710
Imeglimin is a novel new oral compound recently approved for treating type 2 diabetes (T2D) in India. We conducted a systematic review and meta-analysis to evaluate the efficacy of imeglimin in people with T2D in the approved dose of 1000Â mg twice daily (BID).
Effect of dates on blood glucose and other metabolic variables: A narrative review
Sachdev Meenakshi a , Anoop Misra
doi : 10.1016/j.dsx.2023.102705
Volume 17, Issue 2, February 2023, 102705
There is a common belief that individuals with type 2 diabetes mellitus (T2DM) must avoid consumption of dates. This article aims to review and discuss the available studies on dates on different variables, specifically blood glucose.
Increase in hematocrit with SGLT-2 inhibitors - Hemoconcentration from diuresis or increased erythropoiesis after amelioration of hypoxia?
Preethika Ekanayake a, b , Sunder Mudaliar
doi : 10.1016/j.dsx.2022.102702
Volume 17, Issue 2, February 2023, 102702
The SGLT2-inhibitors significantly reduce heart failure hospitalization and progression to end-stage kidney disease. An increase in hemoglobin/hematocrit is seen with SGLT2i-inhibitor treatment. This increase has been attributed to hemoconcentration resulting from a diuretic effect.
Can metformin use reduce the risk of stroke in diabetic patients? A systematic review and meta-analysis
Parsa Paridari a, 1 , Sajjad Jabermoradi a, 1 , Raheleh Gholamzadeh a, b , Somayeh Vazifekhah e , Mohammadhossein Vazirizadeh-Mahabadi a , Shayan Roshdi Dizaji a , Seyed Ali Forouzannia a , Mostafa Hosseini c, d, **, Mahmoud Yousefifard
doi : 10.1016/j.dsx.2023.102721
Volume 17, Issue 2, February 2023, 102721
Stroke and cardiovascular diseases are major causes of death and disability, especially among diabetic patients. Some studies have shown that metformin has been effective in preventing cardiovascular diseases. In this study, we aim to evaluate the effect of metformin on stroke in type 2 diabetic patients.
